Viemed Healthcare Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $301.6M+34.5% YoYTTM through 30 Jun 2026
Net Income $14.5M+28.7% YoYTTM through 30 Jun 2026
Free Cash Flow $29.2MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 56.8% |
| EBITDA Margin | 17.6% |
| Operating Margin | 5.7% |
| Net Margin | 4.8% |
Returns
10.2%ROE
7.7%ROA
10.3%ROIC
Balance Sheet Health
Debt / Equity0.06x
Current Ratio1.13x
Net Debt-$1.5Mnet cash position
Cash & Equivalents$10.7M
Quality Metrics
Altman Z-Score6.14
Piotroski F-Score7 / 9
FCF Margin9.7%
Rule of 4014.9
Earnings-Beat Rate25.0%
Multi-Year Trend
RevenueFY2025: $270.3M
Diluted EPS$0.36TTMFY2025: $0.37
Dividend
No dividend
Capital Allocation
R&D Spend$2.5M
Capex Intensity10.5%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Single reportable segment | View detailsVentilation services declined from 54% of the service mix in Q1 2025 to 47% in Q1 2026 as the company navigates the NCD transition and census pressure. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.